Nobleoak Life (ASX:NOL) ROC (Joel Greenblatt) %: % (As of Dec. 2025)


ASX:NOL Nobleoak Life Ltd ASX:NOL
53 GF Score
Price A$1.19
GF Value A$1.76
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Nobleoak Life ROC (Joel Greenblatt) %?

Nobleoak Life ASX:NOL -5.58% 53 ROC (Joel Greenblatt) % is % as of Dec. 2025. GuruFocus rates ASX:NOL with a GF Score™ of 53/100 and a GF Value™ of A$1.76 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 65 Insurance companies, Nobleoak Life ranks worse than 1538460% on this metric.

ROC (Joel Greenblatt) % does not apply to banks and insurance companies.

ASX:NOL
53GF Score
Nobleoak Life Ltd ASX:NOL
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a ROC (Joel Greenblatt) % of % mean?
Nobleoak Life (ASX:NOL) has a ROC (Joel Greenblatt) % of % as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Nobleoak Life and its competitors. According to the industry distribution chart, Nobleoak Life ranks #999999 out of 65 companies in the Insurance industry.
Is Nobleoak Life's ROC (Joel Greenblatt) % too high?
Nobleoak Life's current ROC (Joel Greenblatt) % is %. Based on the distribution chart, Nobleoak Life ranks #999999 out of 65 companies in the Insurance industry, which is in the bottom quartile relative to peers. Overall, Nobleoak Life has a GF Score™ of 53/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nobleoak Life's ROC (Joel Greenblatt) % compare to AFL and MET?
According to the Insurance industry distribution chart, Nobleoak Life ranks #999999 out of 65 companies for ROC (Joel Greenblatt) %. This places Nobleoak Life in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 79.14. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for an Insurance company?
The median ROC (Joel Greenblatt) % among Insurance companies is 79.14, based on 65 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Nobleoak Life and its competitors. For the Insurance industry, the median ROC (Joel Greenblatt) % is 79.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nobleoak Life's current ROC (Joel Greenblatt) % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nobleoak Life stock overvalued right now?
Based on GuruFocus' analysis, Nobleoak Life (ASX:NOL) is currently considered Significantly Undervalued. The stock's GF Value™ is A$1.76, compared to a current price of A$1.19 — trading 32.7% below its estimated fair value. The current ROC (Joel Greenblatt) % is %. Nobleoak Life's overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Nobleoak Life (ASX:NOL), the current ROC (Joel Greenblatt) % is % as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nobleoak Life (ASX:NOL) Overvalued in 2026?

Based on GuruFocus' analysis, Nobleoak Life stock appears to be undervalued. The current stock price of A$1.19 is trading 32.7% below its estimated GF Value™ of A$1.76. GuruFocus considers Nobleoak Life to be Significantly Undervalued.

Key valuation signals for ASX:NOL:

  • ROC (Joel Greenblatt) %: %
  • GF Value™: A$1.76 vs. price of A$1.19 (32.7% below fair value)
  • GF Score™: 53/100 with 2 warning signs

No single metric tells the full story. See the ASX:NOL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nobleoak Life Business Description

Address 44 Market Street, Level 4, Sydney, NSW, AUS, 2000
Nobleoak Life Ltd is involved in the manufacture and distribution of Life Insurance products (including death, total and permanent disability, trauma, income protection and business expenses insurance) through both its Direct and Strategic Partner (Advised) channels. The company's segments include Direct Business, Strategic Partnerships, and Genus. It generates maximum revenue from the Direct segment.
53GF Score

Get the complete analysis for ASX:NOL

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.19
Price
A$1.76
GF Value